REPORT ON THE AMERICAN SOCIETY FOR THE BONE AND MINERAL RESEARCH CONGRESS - ASBMR 2021 ANNUAL MEETING
About the Authors
A. Y. ZhukovRussian Federation
Competing Interests:
none
A. A. Povaliaeva
Russian Federation
Competing Interests:
none
References
1. Whittier D, Samelson E, Hannan M, et al. A fracture risk assessment tool for high resolution peripheral quantitative computed tomography: The Bone Microarchitecture International Consortium (BoMIC).
2. Alajlouni D, Tran T, Bliuc D, et al. Muscle Strength and Physical Performance Improve Fracture Risk Prediction in Men beyond Garvan and FRAX: The Osteoporotic Fractures in Men (MrOS) Study.
3. Damm T, Schmarje L, Koser N, et al. Artificial intelligence-driven hip fracture prediction based on pelvic radiographs exceeds performance of DXA: the “Study of Osteoporotic Fractures” (SOF).
4. Tripto-Shkolnik L, Szalat A, Tsvetov G, et al. A Six-month Phase 2 Study of Oral PTH in Postmenopausal Women with Low Bone Mass. An Interim Three-Month Analysis.
5. Galitzer H, Santora A, Tripto-Shkolnik L, et al. A Six-month Phase 2 Study of Oral PTH in Postmenopausal Women with Low Bone Mass 6 Month Bone Mineral Density (BMD) results.
6. Kistler-Fischbacher M, Yong JS, Weeks BK, Beck BR. Targeted high-intensity exercise with and without antiresorptive medication to increase bone strength and reduce fracture risk in postmenopausal women: the MEDEX-OP trial.
7. Bilek L, Flores L, Kupzyk K, et al. Bone Loading Exercises Versus Risedronate for the Prevention of Osteoporosis in Postmenopausal Women with Low Bone Mass.
8. Eastell R, Vittinghoff E, Lui L-Y, et al. Validation of the Surrogate Threshold Effect as a Method to Implement Change in BMD as a Surrogate Endpoint for Fracture Outcomes: the FNIH-ASBMR SABRE Project.
Review
For citations:
Zhukov A.Y., Povaliaeva A.A. REPORT ON THE AMERICAN SOCIETY FOR THE BONE AND MINERAL RESEARCH CONGRESS - ASBMR 2021 ANNUAL MEETING. Osteoporosis and Bone Diseases. 2021;24(4):39-40. (In Russ.)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).